Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AUGX

Augmedix (AUGX) Stock Price, News & Analysis

Augmedix logo

About Augmedix Stock (NASDAQ:AUGX)

Advanced Chart

Key Stats

Today's Range
$2.35
$2.35
50-Day Range
$2.29
$2.35
52-Week Range
$0.73
$6.25
Volume
N/A
Average Volume
635,746 shs
Market Capitalization
$115.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.35
Consensus Rating
Hold

Company Overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

AUGX Stock News Headlines

Commure Completes Merger with Augmedix
7 AI Penny Stocks to Watch in October
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …
AUGX Sep 2024 2.500 put
AUGX Sep 2024 2.500 call
AUGX Sep 2024 7.500 call
See More Headlines

AUGX Stock Analysis - Frequently Asked Questions

Augmedix (AUGX) raised $40 million in an initial public offering on Tuesday, October 26th 2021. The company issued 10,000,000 shares at $4.00 per share. William Blair, B. Riley Securities, Benchmark and Lake Street served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Novo Nordisk A/S (NVO).

Company Calendar

Today
6/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Current Symbol
NASDAQ:AUGX
Fax
N/A
Employees
1,430
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.35
High Stock Price Target
$2.35
Low Stock Price Target
$2.35
Potential Upside/Downside
0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.17 million
Pretax Margin
-46.10%

Debt

Sales & Book Value

Annual Sales
$51.58 million
Price / Cash Flow
N/A
Book Value
$0.56 per share
Price / Book
4.20

Miscellaneous

Free Float
43,596,000
Market Cap
$115.07 million
Optionable
Optionable
Beta
-0.22
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:AUGX) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners